Kidney Transplant Research Today is a free monthly online journal that collates and summarizes the latest research about Kidney Transplant, including details on risks, prognosis, procedure, surgery, organ donation.

Volume 2 (2005), Issue 6 (June)

1. Cystatin-C and creatinine as indices of glomerular filtration rate in the immediate follow-up of renal transplant patients.
   Clin Exp Med, 5(1): 14-9. [Abstract] [Full-text]
2. Traumatic stress symptoms in adolescent organ transplant recipients.
   Pediatrics, 115(6): 1640-4. [Abstract] [Full-text]
3. Contrast-enhanced three-dimensional fast-spoiled gradient magnetic resonance angiography of the renal arteries for potential living renal transplant donors: a comparative study with digital subtraction angiography.
   Australas Radiol, 49(3): 214-7. [Abstract] [Full-text]
4. Memokath metallic stent in the treatment of transplant kidney ureter stenosis or occlusion.
   Cardiovasc Intervent Radiol, 28(3): 326-30. [Abstract] [Full-text]
5. Assessing glomerular filtration rate in renal transplant recipients by estimates derived from serum measurements of creatinine and cystatin C.
   Clin Chim Acta, 356(1): 204-11. [Abstract] [Full-text]
6. Acute and hyperacute humoral rejection in kidney allograft recipients treated with anti-human thymocyte antibodies.
   Hum Immunol, 66(5): 501-12. [Abstract] [Full-text]
7. Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection.
   Transpl Immunol, 14(2): 117-21. [Abstract] [Full-text]
8. Quantitative detection of changes in cytokine gene expression in peripheral blood mononuclear cells correlates with and precedes acute rejection in renal transplant recipients.
   Transpl Immunol, 14(2): 99-108. [Abstract] [Full-text]
9. The failed renal transplant: in or out?
   Semin Dial, 18(3): 188-9. [Abstract] [Full-text]
10. The management of the failed renal allograft: an enigma with potential consequences.
    Semin Dial, 18(3): 185-7. [Abstract] [Full-text]
11. At the peril of dialysis patients: ignoring the failed transplant.
    Semin Dial, 18(3): 180-4. [Abstract] [Full-text]
12. Quality of life of patients having renal replacement therapy.
    J Adv Nurs, 51(1): 15-21. [Abstract] [Full-text]
13. Concurrent verrucous and varicelliform rashes following renal transplantation.
    Am J Transplant, 5(7): 1777-80. [Abstract] [Full-text]
14. Transplantation and 6-month follow-up of renal transplantation from a donor with systemic lupus erythematosus and lupus nephritis.
    Am J Transplant, 5(7): 1772-6. [Abstract] [Full-text]
15. CD31+ naïve Th cells are stable during six months following kidney transplantation: implications for post-transplant thymic function.
    Am J Transplant, 5(7): 1764-71. [Abstract] [Full-text]
16. Reversibility of 'secondary hypercalcitoninemia' after kidney transplantation.
    Am J Transplant, 5(7): 1757-63. [Abstract] [Full-text]
17. Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: a systematic review of randomized trials.
    Am J Transplant, 5(7): 1748-56. [Abstract] [Full-text]
18. Management of arterial stenosis affecting kidney graft perfusion: a single-centre study in 53 patients.
    Am J Transplant, 5(7): 1731-8. [Abstract] [Full-text]
19. Patient survival following renal transplant failure in Canada.
    Am J Transplant, 5(7): 1719-24. [Abstract] [Full-text]
20. Increasing incidence of post-kidney transplant anemia in children.
    Am J Transplant, 5(7): 1713-8. [Abstract] [Full-text]
21. Natural history of hepatitis C virus-related liver fibrosis after renal transplantation.
    Am J Transplant, 5(7): 1704-12. [Abstract] [Full-text]
22. Early subclinical coronary artery calcification in young adults who were pediatric kidney transplant recipients.
    Am J Transplant, 5(7): 1689-93. [Abstract] [Full-text]
23. Are we frozen in time? Analysis of the utilization and efficacy of pulsatile perfusion in renal transplantation.
    Am J Transplant, 5(7): 1681-8. [Abstract] [Full-text]
24. Living donor kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) with predominant renal involvement.
    Am J Transplant, 5(7): 1660-70. [Abstract] [Full-text]
25. Workshop on late renal allograft dysfunction.
    Am J Transplant, 5(7): 1600-5. [Abstract] [Full-text]
26. Influence of everolimus on steady-state pharmacokinetics of cyclosporine in maintenance renal transplant patients.
    J Clin Pharmacol, 45(7): 781-91. [Abstract] [Full-text]
27. Desperately seeking "normal": the promise and perils of living with kidney transplantation.
    Soc Sci Med, 61(4): 821-31. [Abstract] [Full-text]
28. Kidney transplantation with two donor ureters in patient with previous ileogastric conduit.
    Transpl Int, 18(7): 884-6. [Abstract] [Full-text]
29. Ultrastructural analysis of the Fisher to Lewis rat model of chronic allograft nephropathy.
    Transpl Int, 18(7): 863-70. [Abstract] [Full-text]
30. Clinical outcome of cadaveric renal allografts contaminated before transplantation.
    Transpl Int, 18(7): 824-7. [Abstract] [Full-text]
31. Open prospective multicenter study of conversion to tacrolimus therapy in renal transplant patients experiencing ciclosporin-related side-effects.
    Transpl Int, 18(7): 816-23. [Abstract] [Full-text]
32. Cyclosporine dose reduction in stable renal transplant patients with high C2 level: simplified method of single C2 measurement and individualization of C0 target.
    Transpl Int, 18(7): 806-10. [Abstract] [Full-text]
33. C4d peritubular capillary staining in chronic allograft nephropathy and transplant glomerulopathy: an uncommon finding.
    Transpl Int, 18(7): 800-5. [Abstract] [Full-text]
34. Impact of pretransplant dialysis on early graft function in pediatric kidney recipients.
    Transpl Int, 18(7): 785-93. [Abstract] [Full-text]
35. Prevalence of cancer history prior to renal transplantation.
    Transpl Int, 18(7): 779-84. [Abstract] [Full-text]
36. Use of Neoral C monitoring: a European consensus.
    Transpl Int, 18(7): 768-78. [Abstract] [Full-text]
37. A simple new technique to prevent bleeding in transplant nephrectomy.
    Int J Urol, 12(5): 522-4. [Abstract] [Full-text]
38. Modifiable factors predicting patient survival in elderly kidney transplant recipients.
    Kidney Int, 68(1): 345-51. [Abstract] [Full-text]
39. Kidney transplantation and wait-listing rates from the international Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Kidney Int, 68(1): 330-7. [Abstract] [Full-text]
40. Chronic renal allograft rejection: pathophysiologic considerations.
    Kidney Int, 68(1): 1-13. [Abstract] [Full-text]
41. Epstein-Barr virus-related primary central nervous system lymphoma after cadaveric renal transplantation improved by treatment with high-dose methotrexate followed by irradiation.
    Nephrology (Carlton), 10(3): 321-4. [Abstract] [Full-text]
42. Complete remission of post-transplant FSGS recurrence by long-term plasmapheresis.
    Pediatr Nephrol, 20(7): 994-7. [Abstract] [Full-text]
43. Circulating endothelial cells in renal transplant recipients.
    Transplant Proc, 37(5): 2387-90. [Abstract] [Full-text]
44. Guidelines for prevention and management of complications following kidney transplantation in rats.
    Transplant Proc, 37(5): 2333-7. [Abstract] [Full-text]
45. Impact of mycophenolate mofetil loading on drug exposure in the early posttransplant period.
    Transplant Proc, 37(5): 2320-3. [Abstract] [Full-text]
46. Cyclosporine and sirolimus interaction in a kidney transplant patient.
    Transplant Proc, 37(5): 2317-9. [Abstract] [Full-text]
47. Ki-67 proliferation index in Kaposi's sarcoma after renal transplantation: findings in skin-only cases versus cases with internal-organ involvement.
    Transplant Proc, 37(5): 2190-4. [Abstract] [Full-text]
48. Study of surgical complications between primary and secondary renal transplants.
    Transplant Proc, 37(5): 2154-6. [Abstract] [Full-text]
49. Correlations between leptin, body composition, bone mineral density, and bone metabolism in kidney transplant recipients.
    Transplant Proc, 37(5): 2151-3. [Abstract] [Full-text]
50. Anemia due to losartan in hypertensive renal transplant recipients without posttransplant erythrocytosis.
    Transplant Proc, 37(5): 2148-50. [Abstract] [Full-text]
51. A simulation model to investigate the impact of cardiovascular risk in renal transplantation.
    Transplant Proc, 37(5): 2135-43. [Abstract] [Full-text]
52. Increased expression of renin in chronic allograft nephropathy.
    Transplant Proc, 37(5): 2131-4. [Abstract] [Full-text]
53. The role of cholecystectomy in renal transplantation.
    Transplant Proc, 37(5): 2129-30. [Abstract] [Full-text]
54. Laparoscopic cholecystectomy for renal transplants.
    Transplant Proc, 37(5): 2127-8. [Abstract] [Full-text]
55. Influence of ganciclovir prophylaxis on citomegalovirus, human herpesvirus 6, and human herpesvirus 7 viremia in renal transplant recipients.
    Transplant Proc, 37(5): 2124-6. [Abstract] [Full-text]
56. Klebsiella pneumoniae peritonitis shortly after kidney transplantation.
    Transplant Proc, 37(5): 2122-3. [Abstract] [Full-text]
57. Variation of CD4+ and CD8+ T lymphocytes as predictor of outcome in renal allograft recipients who developed acute respiratory distress syndrome caused by cytomegalovirus pneumonia.
    Transplant Proc, 37(5): 2118-21. [Abstract] [Full-text]
58. An unusual cause of ureteral obstruction in a renal transplant recipient: ureteric aspergilloma.
    Transplant Proc, 37(5): 2115-7. [Abstract] [Full-text]
59. Percutaneous management of transplant ureteral fistulae is feasible in selected cases.
    Transplant Proc, 37(5): 2111-4. [Abstract] [Full-text]
60. Kidney preserving solutions containing lidocaine may increase urological complication rate after renal transplantation: an in vitro study.
    Transplant Proc, 37(5): 2107-10. [Abstract] [Full-text]
61. Management of coralliform lithiasis on renal allograft with bricker-type ureterointestinal anastomosis.
    Transplant Proc, 37(5): 2104-6. [Abstract] [Full-text]
62. Sildenafil citrate treatment for erectile dysfunction after kidney transplantation.
    Transplant Proc, 37(5): 2100-3. [Abstract] [Full-text]
63. Experiences in kidney transplantation with duplicated ureters.
    Transplant Proc, 37(5): 2096-9. [Abstract] [Full-text]
64. Multiple neoplastic lesions of the lower genital tract in a human papilloma virus-infected kidney-pancreas allograft recipient: a case report.
    Transplant Proc, 37(5): 2093-5. [Abstract] [Full-text]
65. Therapy and prognosis of tumors of the genitourinary tract after kidney transplantation.
    Transplant Proc, 37(5): 2089-92. [Abstract] [Full-text]
66. Hepatocellular carcinoma in renal transplant patients.
    Transplant Proc, 37(5): 2086-8. [Abstract] [Full-text]
67. Hepatitis C virus reactivation in anti-hepatitic C virus-positive renal transplant recipients.
    Transplant Proc, 37(5): 2083-5. [Abstract] [Full-text]
68. Lack of impact of hepatitis C virus coinfection in end-stage renal disease patients with hepatitis B virus infection.
    Transplant Proc, 37(5): 2080-2. [Abstract] [Full-text]
69. Diabetic retinopathy before and after renal transplantation: a longitudinal study.
    Transplant Proc, 37(5): 2077-9. [Abstract] [Full-text]
70. Quality of sleep and quality of life in renal transplantation patients.
    Transplant Proc, 37(5): 2072-6. [Abstract] [Full-text]
71. The cost-effectiveness of basiliximab induction in "old-to-old" kidney transplant programs: Bayesian estimation, simulation, and uncertainty analysis.
    Transplant Proc, 37(5): 2069-71. [Abstract] [Full-text]
72. Early experience with enteric-coated mycophenolate sodium in de novo kidney transplant recipients.
    Transplant Proc, 37(5): 2066-8. [Abstract] [Full-text]
73. Diffuse vascular damage in a transplanted kidney: an indication for nuclear magnetic resonance?
    Transplant Proc, 37(5): 2063-5. [Abstract] [Full-text]
74. Comparison of long-term actual renal allograft survival in mycophenolate mofetil and azathioprine-based triple drug immunosuppression protocols.
    Transplant Proc, 37(5): 2060-2. [Abstract] [Full-text]
75. Delayed renal graft function: the influence of immunosuppression.
    Transplant Proc, 37(5): 2054-9. [Abstract] [Full-text]
76. Different evolution of trough and dose levels during the first year after transplantation for tacrolimus versus cyclosporine.
    Transplant Proc, 37(5): 2051-3. [Abstract] [Full-text]
77. Factors contributing to acute rejection in renal transplantation: the role of noncompliance.
    Transplant Proc, 37(5): 2044-7. [Abstract] [Full-text]
78. Blood cyclosporine level soon after kidney transplantation is a major determinant of rejection: insights from the Mycophenolate Steroid-Sparing Trial.
    Transplant Proc, 37(5): 2037-40. [Abstract] [Full-text]
79. Campath-1H as rescue therapy for the treatment of acute rejection in kidney transplant patients.
    Transplant Proc, 37(5): 2032-6. [Abstract] [Full-text]
80. A randomized study comparing combined spinal epidural or general anesthesia for renal transplant surgery.
    Transplant Proc, 37(5): 2020-2. [Abstract] [Full-text]
81. Comparison of histidine-tryptophan ketoglutarate and University of Wisconsin solutions as primary preservation in renal allografts undergoing pulsatile perfusion.
    Transplant Proc, 37(5): 2016-9. [Abstract] [Full-text]
82. A proposed Saudi approach to the ethical utilization of living unrelated kidney donation.
    Transplant Proc, 37(5): 2004-6. [Abstract] [Full-text]
83. Magnetic resonance imaging as a sole method for the morphological and functional evaluation of live kidney donors.
    BJU Int, 96(1): 111-6. [Abstract] [Full-text]
84. Retroperitoneoscopic donor nephrectomy: a retrospective, non-randomized comparison of early complications, donor and recipient outcome with the standard open approach.
    Eur Urol, 48(1): 90-6; discussion 96. [Abstract] [Full-text]
85. Duplex-Doppler long-term follow-up of renal transplant artery stenosis: case controlled study.
    Ther Apher Dial, 9(3): 265-9. [Abstract] [Full-text]
86. Prevention of early acute rejection with daclizumab and triple immunosuppression in cadaveric renal allograft recipients.
    Ther Apher Dial, 9(3): 262-4. [Abstract] [Full-text]
87. The impact of early cytomegalovirus infection and disease in renal transplant recipients.
    Clin Microbiol Infect, 11(7): 518-30. [Abstract] [Full-text]
88. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism.
    Nephrol Dial Transplant, 20(7): 1311-4. [Abstract] [Full-text]
89. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism.
    Nephrol Dial Transplant, 20(7): 1315-9. [Abstract] [Full-text]
90. Limitations of C2 monitoring in renal transplant recipients.
    Nephrol Dial Transplant, 20(7): 1463-70. [Abstract] [Full-text]
91. Post-transplant diabetes mellitus: risk factors, frequency of transplant rejections, and long-term prognosis.
    Clin Exp Nephrol, 9(2): 164-9. [Abstract] [Full-text]
92. Modified endoscopic live donor nephrectomy: retroperitoneoscopy followed by hand-assistance.
    Int J Urol, 12(6): 603-6. [Abstract] [Full-text]
93. Long-term remission of recurrent parvovirus-B associated anemia in a renal transplant recipient induced by treatment with immunoglobulin and positive seroconversion.
    Transpl Infect Dis, 7(1): 30-3. [Abstract] [Full-text]
94. Living-donor kidney transplantation: a review of the current practices for the live donor.
    J Am Soc Nephrol, 16(7): 2098-110. [Abstract] [Full-text]
95. Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience.
    J Am Soc Nephrol, 16(7): 2225-33. [Abstract] [Full-text]
96. Intrahepatic cytokine profile in renal-transplant patients infected by hepatitis C virus.
    J Med Virol, 76(4): 482-8. [Abstract] [Full-text]

© 2004-2008 Kidney Transplant Research Today. All Rights Reserved.